TOKYO — Japan’s Fujifilm will adopt next fiscal year new technology that uses artificial intelligence to increase its volume of biopharmaceutical drugs by nearly 40% without any additional equipment.
New tech to boost antibody production using current equipment
A staffer works at a Fujifilm contract biopharmaceuticals site in the U.K. The company is pouring billions of dollars into its biopharmaceuticals operations. (Photo by Fujifilm)
KOHEI YAMADA
August 12, 2025 03:04 JST
Read Next
